Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Recent advances in peptide based therapies for obesity and type 2 diabetes ScienceDirect Semaglutide vs Tirzepatide, Cagrilintide, and Retatrutide: Mechanisms & Research Insights Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how